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Svalbard is a Norwegian Archipelago located in the 
Arctic Circle that has a long history of coal-mining. The 
coal is used by the local power-station to provide 
electricity to the residential settlements, as well as being 
exported to countries, e.g. Norway and Germany. Bulk 
coal fly-ash (CFA) produced from the Longyearbyen 
Power-Station was collected by Dr Lisa Mol in 2014. 
Here we report the first geo-toxicological investigation 
of CFA derived from this Artic region. 
 The bulk CFA (Figure 1a) from Svalbard was 
separated into inhalable particles (Figure 1b), as a means 
to test their oxidative capacity in the lung environment. 
Dry CFA was resuspended inside a rotating-drum fitted 
with a PM10-selective inlet head attached to an air-
pump. The air-flow rates of 5, 10 and 20 litres per 
minute produced different sized (i.e. PM 1, 2.5, 10, 












Figure 1. FESEM Svalbard CFA*. 
 
 Analysis of CFA physicochemical properties has 
been on-going (e.g. surface area, size, shape, number, 
metal chemistry) as they are known drivers of the 
oxidative capacity of particulate matter (PM). 
Knowledge of particle size informs on probable 
deposition sites within the lung, and thereby, estimation 
of toxic potential. For example, PM <0.1µm will have 
the greatest toxic effect(s) because nano-sized particles 
readily enter alveoli in the distal respiratory tract to 
provoke inflammation. The main cause of PM 
bioreactivity is believed to be through their induction of 
oxidative stress by generating reactive oxygen species 
(ROS).  
 Ferrous minerals can be found in varying levels in 
CFA depending on the coal geochemistry, and have been 
indicated to cause the most damage through inducing 
ROS via Fenton reactions (Brown et al., 2011). Svalbard 
CFA was exposed to a neodymium magnet in order to 
extract magnetic components. All CFA fractions 
demonstrated a very high-presence of ferrous minerals. 
Accordingly, pure magnetite (Fe2O4) was selected to be a 
positive control particle for assessing CFA toxicity. 
 Preliminary physicochemical characterisation 
involved field-emission scanning electron microscopy 
(FE-SEM) and associated energy dispersive X-ray 
microanalysis (EDX) to determine the inorganic 
elemental composition of bulk and inhalable-sized CFA 
fractions. The oxidative capacity of Svalbard CFA was 
determined by the Plasmid Scission Assay (PSA). PSA 
employs a ROS-sensitive plasmid that exhibits different 
DNA morphologies relative to specific levels of 
‘damage’ (i.e. relaxed, linear and fragmented) versus 
DNA ‘un-damaged’ (i.e. super-coiled); that are captured 
via gel electrophoresis.  
Svalbard CFA caused DNA damage in a dose-
responsive manner; thus inferring toxicity (Figure 2). 
Preliminary results have implied that a dose as low as 
5µg/ml induced minor (i.e. relaxed) DNA damage, with 
the total amount of damage being increased gradually to 
approximately 40% as the CFA concentration increased. 
A TD40 (i.e. Toxic Dose 40%) refers to the dose required 
to kill 40% of the ‘test subject’ (e.g. plasmid DNA or 
lung cells) being challenged by a toxicant. 
 
Figure 2. PSA results on Svalbard CFA 
 
Further analysis of this Artic CFA is required to 
determine the parameters causing bioreactivity. 
Conventional toxicology will include cellular and whole 
organism ROS-assays, including lysis of human red 
blood cells (haemolyses) and detection of 
bioluminescence in Vibrio fischeri, respectively, to 
confirm the acellular PSA results. The indirect effects 
that Svalbard CFA may have on human lungs will 
require investigation of soluble-components (via 
leaching in lung fluids) and bio-availability of other 
metals (using metal-chelators).  
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